156 related articles for article (PubMed ID: 36030863)
21. Pharmaceuticals in drinking water sources and tap water in a city in the middle reaches of the Yangtze River: occurrence, spatiotemporal distribution, and risk assessment.
He P; Wu J; Peng J; Wei L; Zhang L; Zhou Q; Wu Z
Environ Sci Pollut Res Int; 2022 Jan; 29(2):2365-2374. PubMed ID: 34370193
[TBL] [Abstract][Full Text] [Related]
22. [Pharmaceutical residues in aquatic compartments : Status quo and perspectives].
Lipp HP; Lipp A
Urologie; 2022 Nov; 61(11):1208-1216. PubMed ID: 36166057
[TBL] [Abstract][Full Text] [Related]
23. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden.
Bendz D; Paxéus NA; Ginn TR; Loge FJ
J Hazard Mater; 2005 Jul; 122(3):195-204. PubMed ID: 15967274
[TBL] [Abstract][Full Text] [Related]
24. Occurrence of carbamazepine, diclofenac, and their related metabolites and transformation products in a French aquatic environment and preliminary risk assessment.
Zind H; Mondamert L; Remaury QB; Cleon A; Leitner NKV; Labanowski J
Water Res; 2021 May; 196():117052. PubMed ID: 33774347
[TBL] [Abstract][Full Text] [Related]
25. Ranking the risks of eighty pharmaceuticals in surface water of a megacity: A multilevel optimization strategy.
Chen M; Hong Y; Jin X; Guo C; Zhao X; Liu N; Lu H; Liu Y; Xu J
Sci Total Environ; 2023 Jun; 878():163184. PubMed ID: 37001676
[TBL] [Abstract][Full Text] [Related]
26. Understanding the occurrence and distribution of emerging pollutants and endocrine disruptors in sensitive coastal South Florida Ecosystems.
Ng B; Quinete N; Maldonado S; Lugo K; Purrinos J; Briceño H; Gardinali P
Sci Total Environ; 2021 Feb; 757():143720. PubMed ID: 33288250
[TBL] [Abstract][Full Text] [Related]
27. Selected Pharmaceuticals in Different Aquatic Compartments: Part II-Toxicity and Environmental Risk Assessment.
Pereira A; Silva L; Laranjeiro C; Lino C; Pena A
Molecules; 2020 Apr; 25(8):. PubMed ID: 32295269
[TBL] [Abstract][Full Text] [Related]
28. Environmental risk assessment and bioaccumulation of pharmaceuticals in a large urbanized estuary.
Fonseca VF; Duarte IA; Duarte B; Freitas A; Pouca ASV; Barbosa J; Gillanders BM; Reis-Santos P
Sci Total Environ; 2021 Aug; 783():147021. PubMed ID: 34088124
[TBL] [Abstract][Full Text] [Related]
29. Drought impact on pharmaceuticals in surface waters in Europe: Case study for the Rhine and Elbe basins.
Lentz MP; Graham DJ; van Vliet MTH
Sci Total Environ; 2024 Apr; 922():171186. PubMed ID: 38408670
[TBL] [Abstract][Full Text] [Related]
30. Occurrence, bioaccumulation and risk assessment of lipophilic pharmaceutically active compounds in the downstream rivers of sewage treatment plants.
Liu J; Lu G; Xie Z; Zhang Z; Li S; Yan Z
Sci Total Environ; 2015 Apr; 511():54-62. PubMed ID: 25531589
[TBL] [Abstract][Full Text] [Related]
31. Investigation of pharmaceutically active compounds in an urban receiving water: Occurrence, fate and environmental risk assessment.
Liu J; Dan X; Lu G; Shen J; Wu D; Yan Z
Ecotoxicol Environ Saf; 2018 Jun; 154():214-220. PubMed ID: 29476970
[TBL] [Abstract][Full Text] [Related]
32. Neuroactive pharmaceuticals in estuaries: Occurrence and tissue-specific bioaccumulation in multiple fish species.
Duarte IA; Reis-Santos P; Fick J; Cabral HN; Duarte B; Fonseca VF
Environ Pollut; 2023 Jan; 316(Pt 1):120531. PubMed ID: 36397612
[TBL] [Abstract][Full Text] [Related]
33. Predicting environmental risks of pharmaceutical residues by wastewater surveillance: An analysis based on pharmaceutical sales and their excretion data.
Pang L; He K; Zhang Y; Li P; Lin Y; Yue J
Sci Total Environ; 2024 Mar; 916():170204. PubMed ID: 38262535
[TBL] [Abstract][Full Text] [Related]
34. Occurrences of pharmaceuticals in drinking water sources of major river watersheds, China.
Sun J; Luo Q; Wang D; Wang Z
Ecotoxicol Environ Saf; 2015 Jul; 117():132-40. PubMed ID: 25847753
[TBL] [Abstract][Full Text] [Related]
35. Chemicals of emerging concern in the Great Lakes Basin: an analysis of environmental exposures.
Klecka G; Persoon C; Currie R
Rev Environ Contam Toxicol; 2010; 207():1-93. PubMed ID: 20652664
[TBL] [Abstract][Full Text] [Related]
36. Occurrence and ecological risk assessment of pharmaceuticals and cocaine in the urban drainage channels of Santos beaches (São Paulo, Brazil): a neglected, but sensitive issue.
Roveri V; Guimarães LL; Toma W; Correia AT
Environ Sci Pollut Res Int; 2021 Dec; 28(46):65595-65609. PubMed ID: 34322794
[TBL] [Abstract][Full Text] [Related]
37. Occurrence, sources and environmental risk assessment of pharmaceuticals in the Sea of Marmara, Turkey.
Korkmaz NE; Savun-Hekimoğlu B; Aksu A; Burak S; Caglar NB
Sci Total Environ; 2022 May; 819():152996. PubMed ID: 35031378
[TBL] [Abstract][Full Text] [Related]
38. Hydrolysis of amphenicol and macrolide antibiotics: Chloramphenicol, florfenicol, spiramycin, and tylosin.
Mitchell SM; Ullman JL; Teel AL; Watts RJ
Chemosphere; 2015 Sep; 134():504-11. PubMed ID: 25618189
[TBL] [Abstract][Full Text] [Related]
39. Do pharmaceuticals reach and affect the aquatic ecosystems in Brazil? A critical review of current studies in a developing country.
Quadra GR; Oliveira de Souza H; Costa RD; Fernandez MA
Environ Sci Pollut Res Int; 2017 Jan; 24(2):1200-1218. PubMed ID: 27734317
[TBL] [Abstract][Full Text] [Related]
40. Pharmaceuticals in a Mediterranean Basin: The influence of temporal and hydrological patterns in environmental risk assessment.
Palma P; Fialho S; Lima A; Novais MH; Costa MJ; Montemurro N; Pérez S; de Alda ML
Sci Total Environ; 2020 Mar; 709():136205. PubMed ID: 31905561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
